Abstract
Alternative splicing (AS) analysis across the entire spectrum of human prostate cancer evolution reveals the unexpected findings that intron retention is a hallmark of stemness and tumor aggressiveness, and androgen receptor controls a splicing program distinct from its transcriptional regulation. Importantly, twisted activity of the spliceosome causing abnormal AS landscape represents a therapeutic vulnerability in aggressive prostate cancer.
Funding Information
  • National Natural Science Foundation of China (81972418)
  • Wuhan Municipal Science and Technology Bureau (2019020701011490])

This publication has 10 references indexed in Scilit: